I'm LongbridgeAI, I can summarize articles.In Monday's intraday session, Arcellx (ACLX) shares surged 77.6% to $113.83, while Vanda Pharmaceuticals (VNDA) rose 40.41% to $8.09. Other gainers included Genprex (GNPX) up 22.75%, Jyong Biotech (MENS) up 22.69%, and Enhabit (EHAB) up 22.58%. Conversely, Gossamer Bio (GOSS) plummeted 83.5% to $0.35, followed by 20/20 Biolabs (AIDX) down 28.99%, and iSpecimen (ISPC) down 17.38%. Novo Nordisk (NVO) and Neuraxis (NRXS) also saw declines of 15.18% and 14.83%, respectively. The Q4 earnings report was released two days prior.
Gainers
- Arcellx (NASDAQ:ACLX) shares rose 77.6% to $113.83 during Monday's regular session. The market value of their outstanding shares is at $3.7 billion.
- Vanda Pharmaceuticals (NASDAQ:VNDA) stock increased by 40.41% to $8.09. The market value of their outstanding shares is at $340.4 million.
- Genprex (NASDAQ:GNPX) stock moved upwards by 22.75% to $2.19. The company's market cap stands at $4.0 million.
- Jyong Biotech (NASDAQ:MENS) stock increased by 22.69% to $2.47. The company's market cap stands at $152.8 million.
- Enhabit (NYSE:EHAB) shares moved upwards by 22.58% to $13.6. The market value of their outstanding shares is at $561.2 million.
- Fortress Biotech (NASDAQ:FBIOP) shares increased by 20.52% to $13.26. The market value of their outstanding shares is at $37.6 million.
Losers
- Gossamer Bio (NASDAQ:GOSS) stock declined by 83.5% to $0.35 during Monday's regular session. The company's market cap stands at $493.0 million.
- 20/20 Biolabs (NASDAQ:AIDX) shares fell 28.99% to $10.49. The company's market cap stands at $152.9 million.
- iSpecimen (NASDAQ:ISPC) stock declined by 17.38% to $0.23. The market value of their outstanding shares is at $2.7 million.
- Novo Nordisk (NYSE:NVO) shares decreased by 15.18% to $40.23. The market value of their outstanding shares is at $210.8 billion.
- Neuraxis (AMEX:NRXS) shares decreased by 14.83% to $4.71. The company's market cap stands at $58.9 million.
- GRAIL (NASDAQ:GRAL) stock fell 14.03% to $43.17. The company's market cap stands at $1.9 billion. As per the news, the Q4 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.